美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=EMTRICITABINE"
符合检索条件的记录共 76 条
共 4 页，当前第 4 页
首页 上一页 返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE 213926 001 ANDA EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE TABLET;ORAL 200MG;EQ 25MG BASE No No 2024/12/13 2024/12/13 LUPIN LTD Prescription
EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE 208452 001 ANDA EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL 200MG;EQ 25MG BASE;300MG No No 2025/05/20 2025/05/20 MYLAN Prescription
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 216914 002 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 200MG No No 2025/06/24 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 216914 003 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 25MG No No 2025/06/24 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 216914 004 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 30MG No No 2025/06/24 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 216914 005 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 120MG No No 2025/06/24 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 216914 006 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 15MG No No 2025/06/24 (TA) -- CIPLA LTD None (Tentative Approval)
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 211680 002 ANDA EMTRICITABINE, TENOFOVIR ALAFENAMIDE TABLET 25MG No No 2025/10/10 (TA) -- CIPLA LIMITED None (Tentative Approval)
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 211680 003 ANDA EMTRICITABINE, TENOFOVIR ALAFENAMIDE TABLET 10MG No No 2025/10/10 (TA) -- CIPLA LIMITED None (Tentative Approval)
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 211680 004 ANDA EMTRICITABINE, TENOFOVIR ALAFENAMIDE TABLET 120MG No No 2025/10/10 (TA) -- CIPLA LIMITED None (Tentative Approval)
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 211680 005 ANDA EMTRICITABINE, TENOFOVIR ALAFENAMIDE TABLET 15MG No No 2025/10/10 (TA) -- CIPLA LIMITED None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218766 002 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 200MG No No 2025/10/14 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218766 003 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 25MG No No 2025/10/14 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218766 004 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 30MG No No 2025/10/14 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218766 005 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 120MG No No 2025/10/14 (TA) -- CIPLA LTD None (Tentative Approval)
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE 218766 006 ANDA BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLET 15MG No No 2025/10/14 (TA) -- CIPLA LTD None (Tentative Approval)
药品名称，活性成分，申请号搜索 高级检索
©2006-2025 DrugFuture->U.S. FDA Drugs Database